In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...
They called their experimental drug KarXT, and shepherded it through clinical trials to prove its safety and effectiveness.
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...
The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft ...
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
In a proposed guidance, the FDA voiced concerns over whether cancer clinical trials largely or entirely conducted outside the ...